[
  {
    "ts": "2025-11-14T00:07:43+00:00",
    "headline": "Merck nears deal for flu-prevention biotech Cidara",
    "summary": "Merck is nearing a deal to buy Cidara Therapeutics, a drugmaker pioneering a long-acting antibody medicine that protects against flu, after besting...",
    "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "feb600a5-727c-382c-96f3-701294a4a06c",
      "content": {
        "id": "feb600a5-727c-382c-96f3-701294a4a06c",
        "contentType": "STORY",
        "title": "Merck nears deal for flu-prevention biotech Cidara",
        "description": "",
        "summary": "Merck is nearing a deal to buy Cidara Therapeutics, a drugmaker pioneering a long-acting antibody medicine that protects against flu, after besting...",
        "pubDate": "2025-11-14T00:07:43Z",
        "displayTime": "2025-11-14T00:07:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T05:00:00+00:00",
    "headline": "Novo’s New Chairman Urged to Curb Risk After Metsera Drama",
    "summary": "Investors are meeting on Friday to elect Lars Rebien Sorensen to lead the supervisory board less than a week after Novo lost a bidding war with Pfizer Inc. The outcome is a foregone conclusion as the Dane, who ran the company for 16 years, also heads the Novo Nordisk Foundation, the controlling shareholder that holds 77% of Novo’s voting rights.",
    "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "33199485-1b91-3453-ad37-b168daa959a1",
      "content": {
        "id": "33199485-1b91-3453-ad37-b168daa959a1",
        "contentType": "STORY",
        "title": "Novo’s New Chairman Urged to Curb Risk After Metsera Drama",
        "description": "",
        "summary": "Investors are meeting on Friday to elect Lars Rebien Sorensen to lead the supervisory board less than a week after Novo lost a bidding war with Pfizer Inc. The outcome is a foregone conclusion as the Dane, who ran the company for 16 years, also heads the Novo Nordisk Foundation, the controlling shareholder that holds 77% of Novo’s voting rights.",
        "pubDate": "2025-11-14T05:00:00Z",
        "displayTime": "2025-11-14T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74",
          "originalWidth": 1600,
          "originalHeight": 1067,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yyImDYGgGcKqsHHca7ayeQ--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74.cf.webp",
              "width": 1600,
              "height": 1067,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_i5swtQx0TdQo8H5RNH5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/5048dbfd6dc03232007cca42e59d5d74.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-chairman-urged-curb-risk-050000756.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-14T00:07:43+00:00",
    "headline": "Merck nears $9.2bn deal for flu-prevention biotech Cidara",
    "summary": "Merck is nearing a $9.2bn takeover of Cidara Therapeutics, a drugmaker pioneering a long-acting antibody medicine that protects against flu,...",
    "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "feb600a5-727c-382c-96f3-701294a4a06c",
      "content": {
        "id": "feb600a5-727c-382c-96f3-701294a4a06c",
        "contentType": "STORY",
        "title": "Merck nears $9.2bn deal for flu-prevention biotech Cidara",
        "description": "",
        "summary": "Merck is nearing a $9.2bn takeover of Cidara Therapeutics, a drugmaker pioneering a long-acting antibody medicine that protects against flu,...",
        "pubDate": "2025-11-14T00:07:43Z",
        "displayTime": "2025-11-14T00:07:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-nears-deal-flu-treatment-232344334.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CDTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]